Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124799302 | 12479930 | 2 | F | 20111024 | 20160614 | 20160620 | 20160907 | PER | US-JNJFOC-20160424271 | JANSSEN | 56.50 | YR | A | F | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124799302 | 12479930 | 1 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | Y | U | UNKNOWN | 0 | UNSPECIFIED | |||||||
| 124799302 | 12479930 | 2 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | Y | U | UNKNOWN | 0 | UNSPECIFIED | |||||||
| 124799302 | 12479930 | 3 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | Y | U | UNKNOWN | 19813 | UNSPECIFIED | |||||||
| 124799302 | 12479930 | 4 | SS | VIVELLE-DOT | ESTRADIOL | 1 | Transdermal | U | 0 | PATCH | |||||||||
| 124799302 | 12479930 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124799302 | 12479930 | 6 | C | HIZENTRA | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124799302 | 12479930 | 1 | Pain |
| 124799302 | 12479930 | 2 | Pain |
| 124799302 | 12479930 | 3 | Pain |
| 124799302 | 12479930 | 4 | Hormone replacement therapy |
| 124799302 | 12479930 | 5 | Attention deficit/hyperactivity disorder |
| 124799302 | 12479930 | 6 | Immunodeficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124799302 | 12479930 | Application site pain | |
| 124799302 | 12479930 | Back pain | |
| 124799302 | 12479930 | Bone pain | |
| 124799302 | 12479930 | Drug hypersensitivity | |
| 124799302 | 12479930 | Drug ineffective | |
| 124799302 | 12479930 | Peripheral swelling | |
| 124799302 | 12479930 | Skin lesion | |
| 124799302 | 12479930 | Ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124799302 | 12479930 | 1 | 201203 | 0 | ||
| 124799302 | 12479930 | 3 | 200809 | 0 | ||
| 124799302 | 12479930 | 5 | 201108 | 0 | ||
| 124799302 | 12479930 | 6 | 201205 | 0 |